Hepatitis e infection in liver transplant recipients

Liver Transplantation

Volumn 20, Issue 1, 2014, Pages 15-24

  Unzueta, Alberto ^a   Rakela, Jorge ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PEGINTERFERON; RIBAVIRIN; VIRUS RNA;

CHRONIC HEPATITIS; CHRONIC LIVER DISEASE; DIAGNOSTIC ERROR; DISEASE COURSE; FECES ANALYSIS; GRAFT RECIPIENT; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER GRAFT; ORGAN TRANSPLANTATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REVIEW; SERUM; TOXIC HEPATITIS; VIRUS PATHOGENESIS;

ANIMALS; CHRONIC DISEASE; DISEASE PROGRESSION; FECES; FIBROSIS; FOOD MICROBIOLOGY; HEPATITIS E; HUMANS; IMMUNOSUPPRESSION; INTERFERONS; LIVER; LIVER FAILURE; LIVER TRANSPLANTATION; RIBAVIRIN; RNA, VIRAL;

EID: 84896547450     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23764     Document Type: Review

References (69)

1. Hoofnagle JH, Nelson KE, Purcell RH,., Hepatitis E,. N Engl J Med 2012; 367: 1237-1244.
2. Emerson SU, Nguyen HT, Torian U, Burke D, Engle R, Purcell RH,. Release of genotype 1 hepatitis E virus from cultured hepatoma and polarized intestinal cells depends on open reading frame 3 protein and requires an intact PXXP motif. J Virol 2010; 84: 9059-9069.
3. Ahmad I, Holla RP, Jameel S,. Molecular virology of hepatitis E virus. Virus Res 2011; 161: 47-58.
4. Dalton HR, Bendall R, Ijaz S, Banks M,. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis 2008; 8: 698-709.
5. Aggarwal R, Jameel S,. Hepatitis E. Hepatology 2011; 54: 2218-2226.
6. Kamar N, Bendall R, Legrand-Abravanel F, Xia NS, Ijaz S, Izopet J, Dalton HR,. Hepatitis E. Lancet 2012; 379: 2477-2488.
7. Masuda J, Yano K, Tamada Y, Takii Y, Ito M, Omagari K, Kohno S,. Acute hepatitis E of a man who consumed wild boar meat prior to the onset of illness in Nagasaki, Japan. Hepatol Res 2005; 31: 178-183.
8. Sainokami S, Abe K, Kumagai I, Miyasaka A, Endo R, Takikawa Y, et al. Epidemiological and clinical study of sporadic acute hepatitis E caused by indigenous strains of hepatitis E virus in Japan compared with acute hepatitis A. J Gastroenterol 2004; 39: 640-648.
9. Mansuy JM, Bendall R, Legrand-Abravanel F, Sauné K, Miédouge M, Ellis V, et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011; 17: 2309-2312.
10. Meng XJ,. From barnyard to food table: the omnipresence of hepatitis E virus and risk for zoonotic infection and food safety. Virus Res 2011; 161: 23-30.
11. Kamar N, Izopet J, Rostaing L,. Hepatitis E virus infection. Curr Opin Gastroenterol 2013; 29: 271-278.
12. Labrique AB, Sikder SS, Krain LJ, West KP Jr, Christian P, Rashid M, Nelson KE,. Hepatitis E, a vaccine-preventable cause of maternal deaths. Emerg Infect Dis 2012; 18: 1401-1404.
13. Dalton HR, Stableforth W, Thurairajah P, Hazeldine S, Remnarace R, Usama W, et al. Autochthonous hepatitis E in southwest England: natural history, complications and seasonal variation, and hepatitis E virus IgG seroprevalence in blood donors, the elderly and patients with chronic liver disease. Eur J Gastroenterol Hepatol 2008; 20: 784-790.
14. Pischke S, Wedemeyer H,. Chronic hepatitis E in liver transplant recipients: a significant clinical problem? Minerva Gastroenterol Dietol 2010; 56: 121-128.
15. Lewis HC, Wichmann O, Duizer E,. Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review. Epidemiol Infect 2010; 138: 145-166.
16. Teshale EH, Hu DJ, Holmberg SD,. The two faces of hepatitis E virus. Clin Infect Dis 2010; 51: 328-334.
17. Kuniholm MH, Purcell RH, McQuillan GM, Engle RE, Wasley A, Nelson KE,. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009; 200: 48-56.
18. Te HS, Drobeniuc J, Kamili S, Dong C, Hart J, Sharapov UM,. Hepatitis E virus infection in a liver transplant recipient in the United States: a case report. Transplant Proc 2013; 45: 810-813.
19. Bouwknegt M, Engel B, Herremans MM, Widdowson MA, Worm HC, Koopmans MP, et al. Bayesian estimation of hepatitis E virus seroprevalence for populations with different exposure levels to swine in the Netherlands. Epidemiol Infect 2008; 136: 567-576.
20. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Lhomme S, Mansuy JM, Muscari F, et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011; 17: 30-37.
21. Drobeniuc J, Greene-Montfort T, Le NT, Mixson-Hayden TR, Ganova-Raeva L, Dong C, et al. Laboratory-based surveillance for hepatitis E virus infection, United States, 2005-2012. Emerg Infect Dis 2013; 19: 218-222.
22. Legrand-Abravanel F, Kamar N, Sandres-Saune K, Garrouste C, Dubois M, Mansuy JM, et al. Characteristics of autochthonous hepatitis E virus infection in solid-organ transplant recipients in France. J Infect Dis 2010; 202: 835-844.
23. Romanò L, Paladini S, Tagliacarne C, Canuti M, Bianchi S, Zanetti AR,. Hepatitis E in Italy: a long-term prospective study. J Hepatol 2011; 54: 34-40.
24. Slot E, Hogema BM, Riezebos-Brilman A, Kok TM, Molier M, Zaaijer HL,. Silent hepatitis E virus infection in Dutch blood donors, 2011 to 2012. Euro Surveill 2013; 18: 20550.
25. Bendall R, Ellis V, Ijaz S, Ali R, Dalton H,. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010; 82: 799-805.
26. Rossi-Tamisier M, Moal V, Gerolami R, Colson P,. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. J Clin Virol 2013; 56: 62-64.
27. Gyarmati P, Mohammed N, Norder H, Blomberg J, Belák S, Widén F,. Universal detection of hepatitis E virus by two real-time PCR assays: TaqMan and Primer-Probe Energy Transfer. J Virol Methods 2007; 146: 226-235.
28. Jothikumar N, Cromeans TL, Robertson BH, Meng XJ, Hill VR,. A broadly reactive one-step real-time RT-PCR assay for rapid and sensitive detection of hepatitis E virus. J Virol Methods 2006; 131: 65-71.
29. Baylis SA, Blümel J, Mizusawa S, Matsubayashi K, Sakata H, Okada Y, et al.; for HEV Collaborative Study Group. World Health Organization international standard to harmonize assays for detection of hepatitis E virus RNA. Emerg Infect Dis 2013; 19: 729-735.
30. Pas SD, Pronk M, Streefkerk HRA, Beersma MF, Osterhaus ADME, Van Der Eijk AA,. Evaluation of eight commercial hepatitis E virus specific IgM and IgG ELISA assays [abstract]. J Hepatol 2012; 56 (suppl 2): S223-S224.
31. Yoo N, Bernstein J, Caldwell C, Dong C, Drobeniuc J, Kamili S, Landry ML,. Hepatitis E virus infection in a liver transplant recipient: delayed diagnosis due to variable performance of serologic assays. Transpl Infect Dis 2013; 15: E166-E168.
32. Centers for Disease Control and Prevention. Laboratory testing requests. http://www.cdc.gov/hepatitis/HEV/LabTestingRequests.htm. Updated September 14, 2012. Accessed September 2013.
33. Centers for Disease Control and Prevention. Test order: hepatitis E serology, NAT and genotyping. http://www.cdc.gov/laboratory/specimen-submission/ detail.html?CDCTestCode=CDC-10329. Updated January 22, 2013. Accessed September 2013.
34. Baylis SA, Hanschmann KM, Blümel J, Nübling CM,; for HEV Collaborative Study Group. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011; 49: 1234-1239.
35. Chen EY, Baum K, Collins W, Löve A, Merz M, Olafsson S, et al. Hepatitis E masquerading as drug-induced liver injury. Hepatology 2012; 56: 2420-2423.
36. Davern TJ, Chalasani N, Fontana RJ, Hayashi PH, Protiva P, Kleiner DE, et al.; for Drug-Induced Liver Injury Network (DILIN). Acute hepatitis E infection accounts for some cases of suspected drug-induced liver injury. Gastroenterology 2011; 141: 1665-1672.
37. Dalton HR, Fellows HJ, Stableforth W, Joseph M, Thurairajah PH, Warshow U, et al. The role of hepatitis E virus testing in drug-induced liver injury. Aliment Pharmacol Ther 2007; 26: 1429-1435.
38. Kumar Acharya S, Kumar Sharma P, Singh R, Kumar Mohanty S, Madan K, Kumar Jha J, Kumar Panda S,. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol 2007; 46: 387-394.
39. Ramachandran J, Ramakrishna B, Eapen CE, Abraham P, Zachariah UG, Jayram A, et al. Subacute hepatic failure due to hepatitis E. J Gastroenterol Hepatol 2008; 23: 879-882.
40. Péron JM, Bureau C, Poirson H, Mansuy JM, Alric L, Selves J, et al. Fulminant liver failure from acute autochthonous hepatitis E in France: description of seven patients with acute hepatitis E and encephalopathy. J Viral Hepat 2007; 14: 298-303.
41. Feller A, Uchida T, Rakela J,. Acute viral hepatitis superimposed on alcoholic liver cirrhosis: clinical and histopathologic features. Liver 1985; 5: 239-246.
42. Keeffe EB,. Hepatitis A and B superimposed on chronic liver disease: vaccine-preventable diseases. Trans Am Clin Climatol Assoc 2006; 117: 227-237.
43. Kamar N, Selves J, Mansuy JM, Ouezzani L, Péron JM, Guitard J, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008; 358: 811-817.
44. Haagsma EB, van den Berg AP, Porte RJ, Benne CA, Vennema H, Reimerink JH, Koopmans MP,. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transpl 2008; 14: 547-553.
45. Pischke S, Suneetha PV, Baechlein C, Barg-Hock H, Heim A, Kamar N, et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010; 16: 74-82.
46. Buti M, Cabrera C, Jardi R, Castells L, Esteban R,. Are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection? Liver Transpl 2010; 16: 106-107.
47. Kamar N, Garrouste C, Haagsma EB, Garrigue V, Pischke S, Chauvet C, et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology 2011; 140: 1481-1489.
48. Halac U, Béland K, Lapierre P, Patey N, Ward P, Brassard J, et al. Chronic hepatitis E infection in children with liver transplantation. Gut 2012; 61: 597-603.
49. Kamar N, Mansuy JM, Cointault O, Selves J, Abravanel F, Danjoux M, et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008; 8: 1744-1748.
50. Gérolami R, Moal V, Colson P,. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008; 358: 859-860.
51. Haagsma EB,. Reply: are recipients of solid organ transplantation a high-risk population for hepatitis E virus infection? Liver Transpl 2010; 16: 108.
52. Buti M, Domínguez A, Plans P, Jardí R, Schaper M, Espuñes J, et al. Community-based seroepidemiological survey of hepatitis E virus infection in Catalonia, Spain. Clin Vaccine Immunol 2006; 13: 1328-1332.
53. Haagsma EB, Niesters HG, van den Berg AP, Riezebos-Brilman A, Porte RJ, Vennema H, et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl 2009; 15: 1225-1228.
54. Schlosser B, Stein A, Neuhaus R, Pahl S, Ramez B, Krüger DH, et al. Liver transplant from a donor with occult HEV infection induced chronic hepatitis and cirrhosis in the recipient. J Hepatol 2012; 56: 500-502.
55. Suneetha PV, Pischke S, Schlaphoff V, Grabowski J, Fytili P, Gronert A, et al. Hepatitis E virus (HEV)-specific T-cell responses are associated with control of HEV infection. Hepatology 2012; 55: 695-708.
56. Lhomme S, Abravanel F, Dubois M, Sandres-Saune K, Rostaing L, Kamar N, Izopet J,. Hepatitis E virus quasispecies and the outcome of acute hepatitis E in solid-organ transplant patients. J Virol 2012; 86: 10006-10014.
57. Kamar N, Rostaing L, Legrand-Abravanel F, Izopet J,. How should hepatitis E virus infection be defined in organ-transplant recipients? Am J Transplant 2013; 13: 1935-1936.
58. Schildgen O, Müller A, Simon A,. Chronic hepatitis E and organ transplants. N Engl J Med 2008; 358: 2521-2522.
59. Dong C, Zafrullah M, Mixson-Hayden T, Dai X, Liang J, Meng J, Kamili S,. Suppression of interferon-α signaling by hepatitis E virus. Hepatology 2012; 55: 1324-1332.
60. Kamar N, Rostaing L, Abravanel F, Garrouste C, Esposito L, Cardeau-Desangles I, et al. Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation. Clin Infect Dis 2010; 50: e30-e33.
61. Haagsma EB, Riezebos-Brilman A, van den Berg AP, Porte RJ, Niesters HG,. Treatment of chronic hepatitis E in liver transplant recipients with pegylated interferon alpha-2b. Liver Transpl 2010; 16: 474-477.
62. Pischke S, Hardtke S, Bode U, Birkner S, Chatzikyrkou C, Kauffmann W, et al. Ribavirin treatment of acute and chronic hepatitis E: a single-centre experience. Liver Int 2013; 33: 722-726.
63. Junge N, Pischke S, Baumann U, Goldschmidt I, Manns M, Wedemeyer H, Pfister ED,. Results of single-center screening for chronic hepatitis E in children after liver transplantation and report on successful treatment with ribavirin. Pediatr Transplant 2013; 17: 343-347.
64. Mallet V, Nicand E, Sultanik P, Chakvetadze C, Tessé S, Thervet E, et al. Brief communication: case reports of ribavirin treatment for chronic hepatitis E. Ann Intern Med 2010; 153: 85-89.
65. Kamar N, Rostaing L, Abravanel F, Garrouste C, Lhomme S, Esposito L, et al. Ribavirin therapy inhibits viral replication on patients with chronic hepatitis E virus infection. Gastroenterology 2010; 139: 1612-1618.
66. Gerolami R, Borentain P, Raissouni F, Motte A, Solas C, Colson P,. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011; 52: 60-62.
67. Riezebos-Brilman A, Puchhammer-Stöckl E, van der Weide HY, Haagsma EB, Jaksch P, Bejvl I, et al. Chronic hepatitis E infection in lung transplant recipients. J Heart Lung Transplant 2013; 32: 341-346.
68. Chaillon A, Sirinelli A, De Muret A, Nicand E, d'Alteroche L, Goudeau A,. Sustained virologic response with ribavirin in chronic hepatitis E virus infection in heart transplantation. J Heart Lung Transplant 2011; 30: 841-843.
69. Pischke S, Stiefel P, Franz B, Bremer B, Suneetha PV, Heim A, et al. Chronic hepatitis E in heart transplant recipients. Am J Transplant 2012; 12: 3128-3133.